These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8812495)

  • 1. Structural organization of the human PON1 gene.
    Clendenning JB; Humbert R; Green ED; Wood C; Traver D; Furlong CE
    Genomics; 1996 Aug; 35(3):586-9. PubMed ID: 8812495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
    Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
    Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetic mapping and gene structure of mouse paraoxonase/arylesterase.
    Sorenson RC; Primo-Parmo SL; Camper SA; La Du BN
    Genomics; 1995 Dec; 30(3):431-8. PubMed ID: 8825627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
    Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
    Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of paraoxonase (PON1) status requires more than genotyping.
    Richter RJ; Furlong CE
    Pharmacogenetics; 1999 Dec; 9(6):745-53. PubMed ID: 10634137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
    Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
    Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
    Kordonouri O; James RW; Bennetts B; Chan A; Kao YL; Danne T; Silink M; Donaghue K
    Metabolism; 2001 Jun; 50(6):657-60. PubMed ID: 11398141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization of the JEM-1 (BLZF1) gene on human chromosome 1q24: molecular cloning and analysis of its promoter region.
    Tong JH; Fant X; Benoit G; Chen SJ; Chen Z; Lanotte M
    Genomics; 2000 Nov; 69(3):380-90. PubMed ID: 11056056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
    Costa LG; Richter RJ; Li WF; Cole T; Guizzetti M; Furlong CE
    Biomarkers; 2003; 8(1):1-12. PubMed ID: 12519632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of purified human and rabbit serum paraoxonases.
    Kuo CL; La Du BN
    Drug Metab Dispos; 1995 Sep; 23(9):935-44. PubMed ID: 8565784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization of the human beta-catenin gene (CTNNB1).
    Nollet F; Berx G; Molemans F; van Roy F
    Genomics; 1996 Mar; 32(3):413-24. PubMed ID: 8838805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic organization, 5'-flanking region, and chromosomal localization of the human RGS3 gene.
    Chatterjee TK; Eapen A; Kanis AB; Fisher RA
    Genomics; 1997 Oct; 45(2):429-33. PubMed ID: 9344672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
    Primo-Parmo SL; Sorenson RC; Teiber J; La Du BN
    Genomics; 1996 May; 33(3):498-507. PubMed ID: 8661009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.